首页> 美国卫生研究院文献>Elsevier Public Health Emergency Collection >Use of recombinant feline interferon and glucocorticoid in the treatment of feline infectious peritonitis
【2h】

Use of recombinant feline interferon and glucocorticoid in the treatment of feline infectious peritonitis

机译:重组猫干扰素和糖皮质激素在猫传染性腹膜炎治疗中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A total of 12 clinically ill cats previously diagnosed as feline infectious peritonitis (FIP) were treated with a combination of recombinant feline interferon and glucocorticoid. A complete remission (over 2 years) and a partial remission (2 to 5 months) were observed in four (33.3%) and four (33.3%) cases, respectively. Those that survived for more than 2 years were all older cats (6 to 16 years old) with the effusive form of FIP.
机译:用重组猫干扰素和糖皮质激素联合治疗总共12只先前被诊断为猫传染性腹膜炎(FIP)的临床病猫。分别在4例(33.3%)和4例(33.3%)的病例中观察到完全缓解(超过2年)和部分缓解(2至5个月)。存活时间超过2年的猫都是年龄较大的猫(6至16岁),具有喷出性FIP。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号